The market value of the global blood transfusion diagnostics was US$ 3,716.7 million in 2020. The market value of the global blood transfusion diagnostics is forecast to reach US$ 7311.3 million by 2030, growing at a compound annual growth rate (CAGR) of 7% during the forecast period from 2021-2030.
A blood transfusion occurs when one person gives blood to another or a blood component to another by infusing it into the vein. There are four components in blood: red blood cells, white blood cells, platelets, plasma, and clotting factors. Transferring blood requires checking for the presence of all the components. A transfusion can result in the transmission of infection and blood-borne diseases like post-transfusion purpura, anaphylactic reactions, delayed hemolytic reactions, and febrile non-hemolytic reactions.
Factors Influencing Market Growth
Growing awareness about blood transfusion diagnostics to prevent infectious blood-borne diseases and a shift from manual to automated blood banks are driving the growth of the global blood transfusion diagnostics market.
There is a growing demand for the global blood transfusion diagnostics market due to increasing diseases like sickle cell anemia, leukemia, and aplastic anemia, which require blood transfers to increase blood counts and replace blood cells.
Regulatory restrictions and insufficiently skilled operators may slow down the growth of the global blood transfusion diagnostics market.
Automating techniques and developing methods that create efficient results will generate significant opportunities for the global blood transfusion diagnostics market during the forecast period.
Impact Analysis of COVID-19
The COVID-19 outbreak has negatively impacted the market. In addition to reducing voluntary blood donations, the pandemic disrupted the supply chain for medical devices worldwide. During the crisis, blood banks and hospitals faced reduced donor inflows, staff shortages, shortages of blood units, and concerns about transfusion-transmitted COVID-19.
According to American Red Cross estimates, the organization lost around 46,000 blood units due to the pandemic. The lockdown and cancellation of blood drives resulted in a sharp decrease in blood donations at some donor centers.
All major blood centers saw an increase in donations and transfusion procedures across the board in the third quarter of 2020, as most of the major countries lifted lockdown and remain-at-home regulations. Thus, the global market will be able to experience an increase in growth.


Regional Insights
As of 2020, North America held the largest revenue share for blood transfusion diagnostics. It is forecast that the region will continue to grow during the forecast period. The growing awareness of health issues, a high disposable income, decent reimbursement policies, and an established healthcare infrastructure contribute to the market growth. Community Blood Center data indicates that nearly 43,000 pints of donated blood are used every day in both the U.S. and Canada.
The Asia Pacific is forecast to grow at the fastest rate during the forecast period for the blood transfusion diagnostics market. With the launch of various campaigns in India and Australia, awareness about blood donation is rising. In spite of this, decreasing number of donors in Singapore and South Korea has led to fewer adoptions of transfusion diagnostic tools in the Asia Pacific.
Leading Competitors
The leading prominent companies profiled in the global blood transfusion diagnostics market are:
Abbott
BAG Healthcare GmbH
BIOKIT (Werfen)
Bio-Rad Laboratories
Danaher
DiaSorin S.P.A.
F. Hoffmann-La Roche AG
Immucor, Inc.
Ortho Clinical Diagnostics
Quotient Limited
Other Prominent Players
Scope of the Report
The global blood transfusion diagnostics market segmentation focuses on Product, Application, End-use, and Region.
Segmentation based on Product
Reagents & Kits
Instruments
Others
Segmentation based on Application
Blood Grouping
Disease Screening
o Serological Disease Screening
o Molecular Disease Screening
Segmentation based on End-use
Hospitals
Blood Banks
Diagnostic Laboratories
Others
Segmentation based on Region
North America
o The U.S.
o Canada
o Mexico
Europe
? Western Europe
o The UK
o Germany
o France
o Italy
o Spain
o Rest of Western Europe
? Eastern Europe
o Poland
o Russia
o Rest of Eastern Europe
Asia Pacific
o China
o India
o Japan
o Australia & New Zealand
o ASEAN
o Rest of Asia Pacific
Middle East & Africa (MEA)
o UAE
o Saudi Arabia
o South Africa
o Rest of MEA
South America
o Brazil
o Argentina
o Rest of South America

Meta Title: Blood Transfusion Diagnostics Market Industry Analysis, Share and Forecast Till 2030
Meta Description: The market value of the global blood transfusion diagnostics is forecast to reach US$ 7311.3 million by 2030, growing at a compound annual growth rate (CAGR) of 7% during the forecast period from 2021-2030.
Meta Keywords: Blood Transfusion Diagnostics Market, Blood Transfusion Diagnostics Market Size, Blood Transfusion Diagnostics Market Trends, Blood Transfusion Diagnostics Market Insights, Blood Transfusion Diagnostics Market Share, Blood Transfusion Diagnostics Market Forecast